Based on the measurements of operating efficiency obtained from Hyperfine's historical financial statements, Hyperfine may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter. At this time, Hyperfine's Other Current Assets are relatively stable compared to the past year. As of 02/11/2026, Net Invested Capital is likely to grow to about 62.8 M, while Property Plant And Equipment Net is likely to drop slightly above 2.8 M.
The financial analysis of Hyperfine is a critical element in measuring its lifeblood. Investors should carefully consider Hyperfine's ability to pay suppliers or employees on time, ensuring interest payments are not accumulating.
Understanding current and past Hyperfine Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Hyperfine's financial statements are interrelated, with each one affecting the others. For example, an increase in Hyperfine's assets may result in an increase in income on the income statement.
Hyperfine competes with InspireMD, Vivani Medical, Avita Medical, Fonar, and EDAP TMS. Hyperfine, Inc. provides imaging, monitoring, and magnetic resonance imaging products. The company was incorporated in 2014 and is based in Guilford, Connecticut. Hyperfine operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 186 people.
The reason investors look at the income statement is to determine what Hyperfine's earnings per share (EPS) will be for research and analysis purposes. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, this information can be used for research and educational purposes even though its price per share may not have changed.
Comparative valuation techniques use various fundamental indicators to help in determining Hyperfine's current stock value. Our valuation model uses many indicators to compare Hyperfine value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Hyperfine competition to find correlations between indicators driving Hyperfine's intrinsic value. More Info.
Hyperfine is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Hyperfine's Return On Equity is relatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Hyperfine by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.
Most indicators from Hyperfine's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Hyperfine current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hyperfine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.
Today, most investors in Hyperfine Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Hyperfine's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Hyperfine growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of Hyperfine help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Hyperfine. We use our internally-developed statistical techniques to arrive at the intrinsic value of Hyperfine based on widely used predictive technical indicators. In general, we focus on analyzing Hyperfine Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Hyperfine's daily price indicators and compare them against related drivers.
When running Hyperfine's price analysis, check to measure Hyperfine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hyperfine is operating at the current time. Most of Hyperfine's value examination focuses on studying past and present price action to predict the probability of Hyperfine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hyperfine's price. Additionally, you may evaluate how the addition of Hyperfine to your portfolios can decrease your overall portfolio volatility.